PLoS Pathogens · 2008 · 132 citations · 29 references
Life SciencesImmunologyInfectious DiseasesInfectious Disease EpidemiologyMolecular VirologyVirologyAntiviral Drug ResistanceAntiviral PharmacologyAntiviral ResistanceAntiviral TherapyViral EpidemiologyViral InfectionsAdult PrevalenceAntiviral Resistance EpidemiologyAntiviral Susceptibility TestingAntiviral TreatmentInfluenza Antiviral ResistanceInfluenza Antiviral TherapyInfluenza SusceptibilityNeuraminidase Inhibitor Resistance
Surveillance of the antiviral susceptibility of influenza viruses in Europe revealed the emergence of influenza A(H1N1) viruses naturally resistant to the anti-neuraminidase inhibitor oseltamivir (Tamiflu) [1]. Currently, resistant viruses are most prevalent in Europe (25%) but less prevalent in the Americas (16%) or the Western Pacific region (4%) [2]. In Europe, the prevalence varies between countries, with highest levels in Norway (66.5%) and France (46.6%) [3]. These frequencies are in sharp contrast with those observed for H1N1 viruses during previous seasons (0 to <1%) [4]–[8].
29
PHYLIP-Phylogeny inference package (Version 3.2)
Joe Felsenstein · Cladistics · 1989 · 17.9K citations
Isolation of drug-resistant H5N1 virus
Quyet M. Le, Maki Kiso, Kazuhiko Someya et al. · Nature · 2005 · 690 citations